GLYC - GlycoMimetics Inc. (GLYC) Q4 2023 Earnings Call Transcript
2024-03-27 10:27:07 ET
GlycoMimetics, Inc. (GLYC)
Q4 2023 Earnings Conference Call
March 27, 2024 08:30 AM ET
Company Participants
Christian Dinneen-Long - General Counsel
Harout Semerjian - CEO
Edwin Rock - Chief Medical Officer
Bruce Johnson - Chief Commercial Officer
Brian Hahn - CFO
Conference Call Participants
Tara Bancroft - TD Cowen
Naureen Quibria - Capital One Securities
Edward White - H.C. Wainwright
Presentation
Operator
Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. Following management's remarks, we will hold a question-and-answer session. [Operator Instructions]
I would now like to turn the call over to Christian Dinneen-Long, Company Counsel at GlycoMimetics. Please go ahead.
Christian Dinneen-Long
Good morning. Today, we will review our business updates and financial results for the quarter and year ended December 31, 2023. The press release we issued this morning is available on company's website at glycomimetics.com. This call is being recorded and a dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available for 30 days in the Investors section of the company's website....
GlycoMimetics, Inc. (GLYC) Q4 2023 Earnings Call Transcript